Archive

Despite a small decline in members, Discovery Health reports profit. Discover the successful strategies behind their stability.

Ascendis to delist from the JSE as part of its strategy to go private, aiming for operational freedom and agility.

Dive into the Mediscor medicines review 2024 to understand the complexities of rising medicine costs and healthcare sustainability.

Brace for rising medical aid premiums as costs soar beyond inflation rates. Discover the reasons behind this trend.

Understand the crisis in South Africa’s health system under strain, with millions affected by limited resources and high patient volumes.

With dementia increasing in Africa, discover effective strategies to prevent up to 45% of cases and promote brain health.

Find out how a microneedle eyedrop delivery system offers a groundbreaking alternative to traditional eye drops.

Uncover the truth about Kempton Park Hospital security. Learn how millions are spent on a derelict site amidst a healthcare crisis.

Discovery Group’s strong growth delivers a 30% profit surge in its latest results. Discovery Health’s profit grew by 7%.

Delve into the shortage of medical specialists in KZN, which poses serious risks to patient care and healthcare in public hospitals.

\n\nThe decision directly affects the popular GLP-1 agonist drugs, including the active ingredients in brands like Ozempic, Wegovy, and Mounjaro. \n\n\n\nThe WHO’s recommendation aims to pressure pharmaceutical giants to lower prices and encourage the production of affordable generic versions. This is particularly important for people in developing countries, where they are needed most.\n\n\n\nThis move underscores […]